Also, @michaelbg01 has nearly finished a manuscript on the preprint forecasts -- using only the surveys for clarity.
And we are collaborating with @replicats on correlates of good forecasting. (Expecting to mostly corroborate earlier work, but worth a check.)
@ReplicationMkts forecasters:
Now only six covid reprint prizes left to claim: DMS, mudiku, Poison, davison, r6XqxtYY1V, josephharvey6.
https://t.co/heqK8kWBKo
@ReplicationMkts
folks: Anyone know these forecasters? They haven't responded to our prize emails.
In other news, catch the Economist article on mainstream prediction markets: https://t.co/wMvKeXSlHB
Announcing COVID-19 Preprint Market Winners:
https://t.co/heqK8kF0lO
We had 54 winners, with prizes from $16 to $1,269. Congratulations all, and thanks again to all forecasters. And to @FetzerFrFund for the prizes.
@ReplicationMkts
Announcing COVID-19 Preprint Market Winners:
https://t.co/heqK8kF0lO
We had 54 winners, with prizes from $16 to $1,269. Congratulations all, and thanks again to all forecasters. And to @FetzerFrFund for the prizes.
@ReplicationMkts
@AlvaroDeMenard (The fourth nomination for paper #114 was actually the published version of paper #39, similar name and authors but meta-analysis versus early clinical report. More confusingly, #39 changed name and author order
during its four versions on medRxiv.) 2/2
@ReplicationMkts forecasters: We're resolving the COVID-19 *Preprint* markets. Have a look at proposed resolutions before we finalize prizes.
https://t.co/FJ5qmVCEX1
@AlvaroDeMenard We accepted 3 of the 4 nominated publications, and updated prize calculations. Just finished vetting them and it seems we have 61 winners splitting the $10,920, in amounts from about $15 to about $1,280. Plan is to announce details on Monday.
These were the forecasts on future citation and publication for 400 popular COVID-19 preprints.
These prizes were funded by @FetzerFrFund, not DARPA SCORE. Survey prizes were paid in Nov. 2020. Markets had to wait for resolutions in Sep. 2021.
@joshmnicholson Looks like it won't help resolve a JIF-based question, but an interesting metric. Seems to range 0.7 - 1.0 right now, yes?
https://t.co/yK9kChVOzW
We found that SJI does not correlate with the Journal Impact Factor (JIF), which is not surprising because by virtue of how it is calculated (an average number of citations per article) JIF considers all citations, including contradicting and supporting, as equal.
Resolving COVID-400 markets. Anyone have Journal Impact Factors (or similar) for:
* Communications Medicine
* Int'l J. Research in Medical Sciences
* J. of Rare Diseases and Orphan Drugs
* Lancet Microbe
* Lancet Regional Health - Europe
* The Innovation
@replyallguy After U.S. Thanksgiving I'd like to post our forecasting data, which at least will allow comparisons. And the 30 resolutions in Round 11.
(Also prizes for the preprint round. It was kinda strange, but all 400 resolved.)
Prizes, finally!
We are pleased at last to announce the *market* prizes for Replication Markets: 258 winners split $142K, with 121 questions resolving. (We are contacting the winners directly.)
https://t.co/Gh2TgBzk1u